US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

XLRN

Acceleron Pharma (XLRN)

Acceleron Pharma Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XLRN

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
06/04/2017	06:00	Business Wire	Acceleron Announces Clinical Presentations on Luspatercept at the 14th International Symposium on Myelodysplastic Syndromes	NASDAQ:XLRN	Acceleron Pharma Inc
22/03/2017	14:59	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:XLRN	Acceleron Pharma Inc
16/03/2017	06:00	Business Wire	Acceleron Announces Plans to Initiate a Phase 2 Trial of ACE-083 in Charcot-Marie-Tooth Neuromuscular Disease & Host Educatio...	NASDAQ:XLRN	Acceleron Pharma Inc
14/03/2017	17:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XLRN	Acceleron Pharma Inc
08/03/2017	16:45	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:XLRN	Acceleron Pharma Inc
01/03/2017	07:12	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:XLRN	Acceleron Pharma Inc
01/03/2017	06:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:XLRN	Acceleron Pharma Inc
01/03/2017	06:00	Business Wire	Acceleron Reports Fourth Quarter and Year Ended 2016 Operational and Financial Results	NASDAQ:XLRN	Acceleron Pharma Inc
28/02/2017	06:00	Business Wire	Acceleron to Participate in Two Healthcare Investor Conferences in March	NASDAQ:XLRN	Acceleron Pharma Inc
22/02/2017	06:00	Business Wire	Acceleron Pharma to Webcast Conference Call of Fourth Quarter and Year Ended 2016 Financial Results on March 1, 2017	NASDAQ:XLRN	Acceleron Pharma Inc
14/02/2017	09:44	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:XLRN	Acceleron Pharma Inc
01/02/2017	06:00	Business Wire	Acceleron to Participate in Two Healthcare Investor Conferences in February	NASDAQ:XLRN	Acceleron Pharma Inc
06/01/2017	06:00	Business Wire	Acceleron Outlines Corporate Goals and Priorities for 2017	NASDAQ:XLRN	Acceleron Pharma Inc
04/01/2017	06:00	Business Wire	Acceleron to Webcast Presentation at 35th Annual J.P. Morgan Healthcare Conference	NASDAQ:XLRN	Acceleron Pharma Inc
22/12/2016	16:00	Business Wire	Acceleron Announces First Patient Treated in Phase 2 Trial of ACE-083 in Facioscapulohumeral Muscular Dystrophy	NASDAQ:XLRN	Acceleron Pharma Inc
05/12/2016	16:45	Business Wire	Acceleron & Celgene Announce Updated Results from Phase 2 Studies of Luspatercept in Beta-Thalassemia Presented at the 58th A...	NASDAQ:XLRN	Acceleron Pharma Inc
05/12/2016	15:10	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:XLRN	Acceleron Pharma Inc
05/12/2016	06:00	Business Wire	Acceleron & Celgene Announce Preliminary Results from an Investigator Initiated Phase 2 Study of Sotatercept in Myelofibrosis...	NASDAQ:XLRN	Acceleron Pharma Inc
04/12/2016	11:00	Business Wire	Acceleron & Celgene Announce Updated Results from Ongoing Phase 2 Studies of Luspatercept in Myelodysplastic Syndromes at the...	NASDAQ:XLRN	Acceleron Pharma Inc
30/11/2016	06:00	Business Wire	Acceleron Pharma to Host Conference Call & Webcast to Review Data Presented at the 58th American Society of Hematology Annual...	NASDAQ:XLRN	Acceleron Pharma Inc
03/11/2016	15:24	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:XLRN	Acceleron Pharma Inc
03/11/2016	15:05	Business Wire	Acceleron Pharma Reports Third Quarter 2016 Financial and Operational Results	NASDAQ:XLRN	Acceleron Pharma Inc
03/11/2016	08:15	Business Wire	Acceleron Announces New Data Presentations at the 58th American Society of Hematology Annual Meeting and Exposition	NASDAQ:XLRN	Acceleron Pharma Inc
02/11/2016	06:00	Business Wire	Acceleron to Present at Credit Suisse Healthcare Conference Monday, November 7, 2016	NASDAQ:XLRN	Acceleron Pharma Inc
27/10/2016	06:00	Business Wire	Acceleron Pharma to Webcast Conference Call of Third Quarter 2016 Financial Results on November 3, 2016	NASDAQ:XLRN	Acceleron Pharma Inc
13/10/2016	06:00	Business Wire	Acceleron to Host Educational Webcast on Facioscapulohumeral Muscular Dystrophy (FSHD) with Leading Researcher & Provide Over...	NASDAQ:XLRN	Acceleron Pharma Inc
27/09/2016	15:01	Business Wire	Acceleron Announces Retirement of John Knopf as President and CEO; Habib Dable Named as Successor	NASDAQ:XLRN	Acceleron Pharma Inc
31/08/2016	06:00	Business Wire	Acceleron to Participate in Three Healthcare Investor Conferences in September	NASDAQ:XLRN	Acceleron Pharma Inc
04/08/2016	06:00	Business Wire	Acceleron Pharma Reports Second Quarter 2016 Financial and Operational Results	NASDAQ:XLRN	Acceleron Pharma Inc
28/07/2016	06:00	Business Wire	Acceleron Pharma to Webcast Conference Call of Second Quarter 2016 Financial Results on August 4, 2016	NASDAQ:XLRN	Acceleron Pharma Inc

Showing the most relevant articles for your search:NASDAQ:XLRN

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 Próxima >

Verizon Communications

American Express

Energy Select Sector SPDR

Financial Select Sector

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones